Drug details

Bravelle (urofollitropin injection)

type of Ovulation Stimulators, Gonadotropins

Bravelle (urofollitropin) for Injection is a purified form of a hormone called follicle-stimulating hormone (FSH) used to treat infertility in women whose own natural FSH is not sufficient in stimulating follicles to mature. Bravelle also is used to help the ovaries produce multiple eggs for use in "in vitro" fertilization.

This drug may have the following side effects:

• nausea,
• vomiting,
• skin rash,
• constipation,
• headache,
• acne
• bloating,
• cramps,
• mild stomach/abdominal pain,
• mild pelvic pain,
• injection site reactions (redness, pain, swelling, itching, or irritation),
• breast tenderness/pain,
• hot flashes, or

The following drugs are related to Bravelle, either as a replacement or used together:

• ExEm Foam (air polymer-type a intrauterine foam)
• Cetrotide (cetrorelix)
• Ovidrel (choriogonadotropin alfa injection)
• Pregnyl (chorionic gonadotropin for injection)
• Clomid (clomiphene)
• Fertinex (urofollitropin)
• Follistim AQ (follitropin beta)
• Gonal-F (follitropin alfa)
• Gonal-f RFF (follitropin alfa injection)
• Menopur (menotropins injection)
• Repronex (menotropins for injection)
• Milprosa (progesterone vaginal system)